Showing results 65 to 84 of 89
< previous
next >
| Issue Date | Title | Type | Author(s) |
| 2009 | Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells | Articulo | Larrea, E. (Esther) ; Aldabe, R. (Rafael); Gonzalez, I. (Iranzu); Segura, V. (Víctor); Sarobe, P. (Pablo); Echeverria, I. (Itziar); Prieto, J. (Jesús) |
| 1994 | Overcoming class II-linked non-responsiveness to hepatitis B vaccine | Articulo | Hervas-Stubbs, S. (Sandra); Berasain, C. (Carmen); Golvano, J.J. (José Javier); Lasarte, J.J. (Juan José); Prieto, I. (Isidro); Sarobe, P. (Pablo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 2009 | Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy | Articulo | Llopiz, D. (Diana); Dotor, J. (Javier); Casares, N. (Noelia); Bezunartea, J. (Jaione); Diaz-Valdes, N. (Nancy); Ruiz, M. (Marta); Aranda, F. (Fernando); Berraondo, P. (Pedro); Prieto, J. (Jesús); Lasarte, J.J. (Juan José); Borras-Cuesta, F. (Francisco); Sarobe, P. (Pablo) |
| 1990 | Polarity of immunogens: implications for vaccine design | Articulo | Golvano, J.J. (José Javier); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 2023 | Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma | Articulo | Larrayoz, M. (Marta); García-Barchino, M.J. (María José); Celay, J. (Jon); Etxebeste-Mitxeltorena, A. (Amaia); Jiménez-Andrés, M. (Maddalen); Perez, C. (Cristina); Ordóñez-Ciriza, R. (Raquel); Cobaleda, C. (César); Botta, C. (Cirino); Fresquet, V. (Vicente); Roa, S. (Sergio); Goicoechea, I. (Ibai); Maia, C. (Catarina); Lasaga, M. (Miren); Chesi, M. (Marta); Bergsagel, P.L. (P. Leif); Larrayoz, M.J. (María J.); Calasanz-Abinzano, M.J. (Maria Jose); Campos-Sanchez, E. (Elena); Martínez-Cano, J. (Jorge); Panizo, C. (Carlos); Rodriguez-Otero, P. (Paula); Vicent, S. (Silvestre); Roncador, G. (Giovanna); Gonzalez, P. (Patricia); Takahashi, S. (Satoru); Katz, S.G. (Samuel G.); Walensky, L.D. (Loren D.); Ruppert, S.M. (Shannon M.); Lasater, E.A. (Elisabeth A.); Amann, M. (Maria); Lozano-Moreda, T. (Teresa); Llopiz, D. (Diana); Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Planell, N. (Núria); Gomez-Cabrero, D. (David); Kudryashova, O. (Olga); Kurilovich, A. (Anna); Revuelta, M.V. (Maria V.); Cerchietti, L. (Leandro); Aguirre-Ena, X. (Xabier); San-Miguel, J.F. (Jesús F.); Paiva, B. (Bruno); Prosper-Cardoso, F. (Felipe); Martinez-Climent, J.A. (José Ángel) |
| 1996 | Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment | Articulo | Sarobe, P. (Pablo); Jauregui, J.I. (Javier Ignacio); Lasarte, J.J. (Juan José); Garcia, N. (Nicolás); Civeira, M.P. (María Pilar); Borras-Cuesta, F. (Francisco); Prieto, J. (Jesús) |
| 1995 | Simple strategy to induce antibodies of distinct specificity: application to the mapping of gp120 and inhibition of HIV-1 infectivity | Articulo | Prieto, I. (Isidro); Hervas-Stubbs, S. (Sandra); Garcia-Granero, M. (Marta); Berasain, C. (Carmen); Riezu-Boj, J.I. (José Ignacio); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 2000 | Specific and general HLA-DR binding motifs: comparison of algorithms | Articulo | Borras-Cuesta, F. (Francisco); Golvano, J.J. (José Javier); Garcia-Granero, M. (Marta); Sarobe, P. (Pablo); Riezu-Boj, J.I. (José Ignacio); Huarte, E. (Eduardo); Lasarte, J.J. (Juan José) |
| 1999 | Synthesis and anti-HIV-1 activities of new pyrimido[5,4-b]indoles | Articulo | Merino, I. (Isidro); Monge, A. (Antonio); Font, M. (María); Martinez-de-Irujo, J.J. (Juan José); Alberdi, E. (Elena); Santiago, E. (Esteban); Prieto, I. (Isidro); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco) |
| 1997 | Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivatives | Articulo | Font, M. (María); Monge, A. (Antonio); Alvarez, E. (E.); Cuartero, A. (A); Losa, M.J. (M.J.); Fidalgo, M.J. (M. J.); Sanmartin-Grijalba, C. (Carmen); Nadal, E. (Ernest); Ruiz, I. (I); Merino, I. (Isidro); Martinez-Irujo, J.J. (Juan José); Alberdi, E. (Elena); Santiago, E. (Esteban); Prieto, I. (Inés); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco) |
| 1997 | Synthesis and evaluation of new Reissert analogs as HIV-1 RT inhibitors. 2. Benzo[f]quinoline and pyridine derivatives | Articulo | Monge, A. (Antonio); Alvarez, E. (E.); Sanmartin-Grijalba, C. (Carmen); Nadal, E. (Ernest); Ruiz, I. (I); Font, M. (María); Martinez-Irujo, J.J. (Juan José); Santiago, E. (Esteban); Prieto, I. (Inés); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco) |
| 2001 | T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine | Articulo | Hervas-Stubbs, S. (Sandra); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Vivas, I. (Isabel); Condreay, L. (Lynn); Cullen, J.M. (John M.); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1999 | T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides | Articulo | Lopez-Diaz-de-Cerio, A. (Ascensión); Casares, N. (Noelia); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Perez-Mediavilla, L.A. (Luis Alberto); Ruiz, M. (Marta); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 2007 | The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN gamma | Articulo | Arina, A. (Ainhoa); Murillo, O. (Oihana); Hervas-Stubbs, S. (Sandra); Azpilicueta, A. (Arantza); Dubrot, J. (Juan); Tirapu, I. (Íñigo); Huarte, E. (Eduardo); Alfaro, C. (Carlos); Perez-Gracia, J.L. (Jose Luis); González-Aseguinolaza, G. (Gloria); Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Jamieson, A. (Amanda); Prieto, J. (Jesús); Raulet, D.H. (David H.); Melero, I. (Ignacio) |
| 2009 | The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression | Articulo | Pardo-Saganta, A. (Ana); Latasa, M.U. (María Ujué); Castillo, J. (Josefa); Alvarez-Asiain, L. (Laura); Perugorria, M.J. (María J.); Sarobe, P. (Pablo); Rodriguez-Ortigosa, C.M. (Carlos M.); Prieto, J. (Jesús); Berasain, C. (Carmen); Santamaria, M. (Mónica); Avila, M.A. (Matías Antonio) |
| 2007 | The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo | Articulo | Lasarte, J.J. (Juan José); Casares, N. (Noelia); Gorraiz, M. (Marta); Hervas-Stubbs, S. (Sandra); Arribillaga, L. (Laura); Mansilla, C. (Cristina); Durantez, M. (Maika); Llopiz, D. (Diana); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco); Prieto, J. (Jesús); Leclerc, C. (Claude) |
| 2017 | The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer | Articulo | Villanueva, L. (Lorea); Silva, L. (Leyre); Llopiz, D. (Diana); Ruiz, M. (Marta); Iglesias-Alonso, T. (Tamara); Lozano-Moreda, T. (Teresa); Casares, N. (Noelia); Hervas-Stubbs, S. (Sandra); Rodríguez, M.J. (María José); Carrascosa, J.L. (José L.); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo) |
| 2011 | Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis | Articulo | Arribillaga, L. (Laura); Dotor, J. (Javier); Basagoiti, M. (María); Riezu-Boj, J.I. (José Ignacio); Borras-Cuesta, F. (Francisco); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Cornet, M.E. (María Eugenia); Feijoo, E. (Esperanza) |
| 1997 | Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection | Articulo | Hervas-Stubbs, S. (Sandra); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Prieto, J. (Jesús); Cullen, J.M. (John M.); Roggendorf, M. (Michael); Borras-Cuesta, F. (Francisco) |
| 2022 | Therapeutic vaccines against hepatocellular carcinoma in the immune checkpoint inhibitor era: time for neoantigens? | Revision | Repáraz-Pernaut, D. (David); Aparicio-De-la-Torre, B. (Belén); Llopiz, D. (Diana); Hervas-Stubbs, S. (Sandra); Sarobe, P. (Pablo) |
